External use drug for treating climacteric syndrome and preparation method thereof

Abstract

The invention provides an external use drug for treating climacteric syndrome and further discloses a preparation method of the external use drug. The external use drug for treating the climacteric syndrome is good in therapeutic effect and convenient to take. The technical point is that the external use drug for the treating climacteric syndrome is composed, by weight, of 3%-6% of angelica sinensis, 1%-3% of ligusticum, 1%-3% of ligusticum wallichii, 3%-6% of Chinese yam, 1%-3% of veratrum album, 2%-5% of chasteberry, 3%-6% of soybean, 3%-7% of polyethylene glycol, 1%-3% of twain-80, 1%-3% of potassium hydroxide, 2%-4% of carbomer 2020,1%-3% of hydroxyethylcellulose, 10%-18% of ethanol,1%-3% of jiema bp and 30%-45% of deionized water. The external use drug belongs to the technical field of traditional Chinese medicine preparation.

Description

technical field [0001] The invention discloses a medicine for treating climacteric syndrome, specifically, an externally used medicine for treating climacteric syndrome, and belongs to the technical field of traditional Chinese medicine preparation. Background technique [0002] Menopausal syndrome is a series of symptoms caused by a drop in estrogen levels. A small number of women have obvious symptoms because the body cannot adapt quickly, but generally do not need special treatment. Very few symptoms are severe, and even affect life and work, you need to use Chinese medicine Yishen Gengniankang for treatment. It is generally believed that after women enter menopause, changes in their family and social environment can increase their physical and mental burdens, making menopausal syndrome prone to occur or aggravating certain existing symptoms. Some women with unstable mental state themselves have more obvious menopausal syndrome, even moody. Although menopausal syndrome...

AI Technical Summary

Problems solved by technology

[0007] Currently used in the market such as: topical hormone patch, first, skin ulceration and allergies are not uncommon due to the plaster preparation is to take the package therapy; second, there are still many shortcomings in the current sex hormone replacement therapy, such as increasing the burden on the liver, increasing the endometrium Cancer, breast cancer, thrombotic disease, the incidence of cholelithiasis, etc., cause certain risks to women receiving treatment; three, rubber plaster has the disadvantages of poor air permeability, skin irritation, and easy allergies; four, gel The curing time of the plaster is not easy to control, the adhesion is poor, and the paste overflows, etc.